Zoonotic Intestinal Parasites of Dogs: Transmission Risks and Public Health Implications
Etiological Agents and Host Specificity
The question "are dog intestinal parasites contagious to humans" is central to veterinary public health. A diverse assemblage of helminths and protozoa colonize the canine gastrointestinal tract, and a substantial subset of these agents possess the biological capacity for cross-species transmission. The principal zoonotic intestinal parasites of dogs include the nematodes Toxocara canis, Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala, and Trichuris vulpis; the cestodes Dipylidium caninum, Taenia species (with Echinococcus granulosus and Echinococcus multilocularis representing the most significant public health threats); and the protozoa Giardia duodenalis (assemblages A and B), Cryptosporidium parvum (primarily the zoonotic IIa subtypes), and Cystoisospora (formerly Isospora) species, though the latter are considered largely host-specific [1, 2, 3]. The zoonotic potential of each parasite is determined by its life cycle, host range, and the capacity of its infective stages to survive in the external environment and to establish patent infections in human hosts [4, 5].
Epidemiology and Prevalence
The global prevalence of these parasites in canine populations is highly variable and is influenced by geographic region, climate, management practices, and the availability of veterinary care [6, 7]. In a meta-analysis of fecal prevalence surveys, Toxocara canis was identified in 5.1% to 39.2% of dogs sampled, with the highest prevalence observed in puppies and free-roaming populations [8, 9]. Ancylostoma caninum prevalence in tropical and subtropical regions can exceed 50% in untreated shelter dogs, while Trichuris vulpis is reported at 1.3% to 14.4% in North American surveys [10, 11]. Giardia duodenalis prevalence, as determined by immunofluorescence or PCR, ranges from 2.5% to 45% depending on the population and diagnostic sensitivity [12, 13]. Cryptosporidium species prevalence in dogs is generally lower, typically under 10%, but is of particular concern in immunocompromised human contacts [14, 15]. The prevalence of Echinococcus granulosus is restricted to regions where pastoral practices allow dogs access to infected livestock offal, while Echinococcus multilocularis is endemic in the northern hemisphere, with prevalence in red foxes (Vulpes vulpes) and dogs ranging from 1% to 40% in hyperendemic foci [16, 17, 18].
Transmission Pathways and Infective Stages
The biological mechanisms by which these parasites are transmitted from dogs to humans are well characterized. For the question "are dog intestinal parasites contagious to humans", the answer is affirmative for several key agents, and the transmission routes are distinct for each taxonomic group.
Nematode Transmission
Toxocara canis produces embryonated eggs that are shed in canine feces. These eggs undergo a mandatory period of embryonation in the environment (typically 2 to 4 weeks at optimal temperatures of 25 to 30 degrees Celsius) to become larvated, infective stages [19, 20]. Humans acquire infection through the accidental ingestion of these eggs via contaminated soil, fomites, or unwashed hands [21, 22]. The eggs are highly resistant to environmental desiccation and can remain viable in soil for years [23, 24]. Ancylostoma caninum and A. braziliense have a dual transmission pathway: humans can be infected percutaneously by third-stage filariform larvae (L3) present in contaminated soil or grass, and also orally through ingestion of L3 larvae [25, 26]. The percutaneous route is the primary mechanism for cutaneous larva migrans (CLM) in humans, where the larvae penetrate the skin but are unable to complete their life cycle in the human host, resulting in a self-limiting but intensely pruritic dermatitis [27, 28].
Cestode Transmission
Echinococcus granulosus and E. multilocularis are small tapeworms (2 to 6 mm) that reside in the small intestine of the definitive canine host [29, 30]. The adult worms shed proglottids containing eggs into the feces. These eggs are immediately infective to intermediate hosts, including humans, upon ingestion [31, 32]. The oncosphere, a six-hooked larva, hatches in the small intestine, penetrates the intestinal wall, and migrates via the portal circulation to the liver, lungs, or other viscera, where it develops into a hydatid cyst [33, 34]. Dipylidium caninum is transmitted to humans via the accidental ingestion of infected fleas (Ctenocephalides felis or C. canis) or lice that contain the cysticercoid larval stage [35, 36]. This is a classic example of a vector-borne parasite where the flea serves as the obligate intermediate host [37].
Protozoan Transmission
Giardia duodenalis is transmitted via the fecal-oral route through the ingestion of cysts. The cyst is the environmentally resistant stage, capable of surviving for weeks in cold water and for months in moist soil [38, 39]. The excystation process, triggered by gastric acid and pancreatic enzymes, releases two trophozoites that colonize the duodenum and jejunum [40, 41]. Cryptosporidium parvum is transmitted via the fecal-oral route through the ingestion of oocysts. The oocyst is highly resistant to chlorine and standard water treatment, and a low infectious dose (ID50 of approximately 10 to 30 oocysts) makes it a significant waterborne pathogen [42, 43, 44].
Clinical Signs and Pathogenesis in Dogs
The clinical manifestations of these infections in dogs are often subclinical, but can be severe, particularly in young, debilitated, or co-infected animals [45, 46].
Toxocara canis
In puppies, the life cycle involves transplacental (prenatal) and transmammary (lactational) transmission of arrested L3 larvae [47, 48]. The larvae migrate through the liver and lungs, causing a verminous pneumonia, before being coughed up and swallowed to reach the small intestine [49, 50]. Clinical signs include a pot-bellied appearance, poor growth, diarrhea, and vomiting of adult worms [51, 52].
Ancylostoma caninum
The adult hookworms attach to the intestinal mucosa via their buccal capsules and feed on blood, causing a chronic, iron-deficiency anemia [53, 54]. The pathogenesis involves the secretion of anticoagulant peptides (e.g., AcAP-5 and AcAP-6) that inhibit platelet aggregation and coagulation factor Xa, leading to persistent blood loss [55, 56]. Clinical signs include melena, pale mucous membranes, and progressive weakness [57, 58].
Giardia duodenalis
The trophozoites adhere to the microvilli of the duodenal epithelium via a ventral disc, causing a disruption of the brush border and a malabsorptive diarrhea [59, 60]. The pathogenesis is multifactorial, involving villous atrophy, crypt hyperplasia, and a reduction in disaccharidase enzyme activity [61, 62]. Clinical signs include acute or chronic, foul-smelling, steatorrheic diarrhea, with or without vomiting [63, 64].
Cryptosporidium parvum
The parasite invades the microvillus border of enterocytes, where it resides in an intracellular but extracytoplasmic parasitophorous vacuole [65, 66]. The infection causes a mild to moderate enteritis, with clinical signs ranging from self-limiting diarrhea in immunocompetent dogs to severe, life-threatening diarrhea in immunocompromised or neonatal animals [67, 68].
Pathology and Host-Parasite Interactions
The pathological changes induced by these parasites are largely a function of the host immune response and the parasite's immune evasion strategies [69, 70].
Nematode Pathology
For Toxocara canis, the hepatic phase of larval migration results in a granulomatous hepatitis characterized by eosinophilic infiltration and focal necrosis [71, 72]. The pulmonary phase causes an eosinophilic pneumonitis with alveolar hemorrhage and edema [73, 74]. In Ancylostoma caninum, the intestinal pathology is characterized by a hemorrhagic, catarrhal enteritis with a marked eosinophilic and mast cell infiltration at the attachment sites [75, 76]. The chronic blood loss leads to a regenerative, microcytic, hypochromic anemia [77, 78].
Cestode Pathology
Echinococcus granulosus in the canine host is typically non-pathogenic, with no significant intestinal pathology [79, 80]. The adult worms are attached to the crypts of Lieberkühn, and the host response is minimal [81, 82]. The pathology is entirely in the intermediate host, where the expanding hydatid cyst causes a space-occupying lesion, leading to organ dysfunction and, in the case of hepatic cysts, biliary obstruction [83, 84].
Protozoan Pathology
Giardia duodenalis infection in dogs is associated with a reduction in the surface area of the small intestine, leading to a malabsorptive state [85, 86]. The histopathology reveals a mild to moderate lymphoplasmacytic and eosinophilic infiltration of the lamina propria [87, 88]. Cryptosporidium parvum causes a similar pattern of villous atrophy and crypt hyperplasia, with a predominantly neutrophilic infiltrate [89, 90].
Diagnostic Approaches
The diagnosis of these infections relies on the detection of parasite-specific stages in fecal samples, using a combination of morphological and molecular techniques [91, 92].
Fecal Flotation and Sedimentation
The standard diagnostic method is centrifugal fecal flotation using a high-specific-gravity solution (e.g., zinc sulfate at 1.18 to 1.20 specific gravity, or Sheather's sugar solution at 1.27 specific gravity) [93, 94]. This technique is effective for the recovery of Toxocara canis eggs (75 to 90 micrometers, thick-shelled, with a pitted surface), Ancylostoma caninum eggs (55 to 75 micrometers, thin-shelled, with a smooth, morulated interior), and Trichuris vulpis eggs (70 to 90 micrometers, barrel-shaped with bipolar plugs) [95, 96]. For Giardia cysts, zinc sulfate flotation is preferred, as it preserves the cyst morphology and allows for visualization of the internal structures [97, 98]. For Cryptosporidium oocysts, a modified Ziehl-Neelsen acid-fast stain or a direct immunofluorescence assay (DFA) is required, as the oocysts are small (4 to 6 micrometers) and are not reliably detected by standard flotation [99, 100].
Molecular Diagnostics
Polymerase chain reaction (PCR) assays, including conventional PCR, nested PCR, and quantitative real-time PCR (qPCR), are used for species and genotype identification [101, 102]. For Giardia duodenalis, PCR targeting the beta-giardin gene, the triose phosphate isomerase (TPI) gene, or the 18S rRNA gene is used to differentiate between the zoonotic assemblages A and B and the host-specific assemblages C and D [103, 104]. For Cryptosporidium parvum, PCR targeting the 18S rRNA gene and the COWP gene is used for species identification, and gp60 subtyping is used for epidemiological tracking [105, 106]. For Echinococcus species, PCR targeting the mitochondrial 12S rRNA gene or the NADH dehydrogenase subunit 1 (ND1) gene is used for definitive diagnosis and for differentiating E. granulosus from E. multilocularis [107, 108].
Immunological Assays
Enzyme-linked immunosorbent assays (ELISAs) are available for the detection of Giardia and Cryptosporidium antigens in fecal samples [109, 110]. These assays use monoclonal antibodies directed against the cyst wall or oocyst wall antigens and have a sensitivity of 85% to 95% compared to PCR [111, 112]. Fecal antigen tests for Toxocara canis are not widely used, as the egg count by flotation is the standard of care [113, 114].
Treatment and Anthelmintic Strategies
The treatment of these infections is guided by the specific parasite and the drug's spectrum of activity [115, 116].
Nematode Treatment
Fenbendazole (50 mg/kg orally for 3 to 5 consecutive days) is the drug of choice for Toxocara canis, Ancylostoma caninum, and Trichuris vulpis [117, 118]. It acts by binding to the parasite's beta-tubulin, inhibiting microtubule polymerization and disrupting glucose uptake [119, 120]. Pyrantel pamoate (5 to 10 mg/kg) is effective against Toxocara canis and Ancylostoma caninum but is not effective against Trichuris vulpis [121, 122]. Milbemycin oxime (0.5 mg/kg) and moxidectin (2.5 to 3.0 mg/kg) are macrocyclic lactones that are effective against Toxocara canis and Ancylostoma caninum and are used in monthly heartworm prevention products [123, 124].
Cestode Treatment
Praziquantel (5 mg/kg) is the drug of choice for Dipylidium caninum and Echinococcus species [125, 126]. It acts by increasing the permeability of the cestode tegument to calcium ions, causing a rapid paralysis and detachment of the worm [127, 128]. Epsiprantel (2.5 to 5 mg/kg) is an alternative for Dipylidium caninum [129, 130].
Protozoan Treatment
Metronidazole (25 mg/kg twice daily for 5 to 7 days) is the standard treatment for Giardia duodenalis in dogs, though resistance is emerging [131, 132]. Fenbendazole (50 mg/kg for 3 to 5 days) is also effective against Giardia [133, 134]. Paromomycin (25 to 35 mg/kg twice daily for 5 to 7 days) is an aminoglycoside used for Cryptosporidium in dogs, but its use is limited by nephrotoxicity [135, 136]. Nitazoxanide (25 mg/kg twice daily for 3 to 7 days) is a thiazolide that has shown efficacy against Cryptosporidium in some studies [137, 138].
Control and Prevention
The control of these zoonotic infections requires a multi-pronged approach targeting the parasite at the level of the host, the environment, and the vector [139, 140].
Environmental Decontamination
The removal of feces from the environment is the single most effective control measure [141, 142]. Feces should be collected daily and disposed of in a sealed container [143, 144]. For Toxocara canis eggs, the use of high-pressure steam or heat (temperatures above 60 degrees Celsius) is required to kill the eggs, as they are resistant to most chemical disinfectants [145, 146]. For Cryptosporidium oocysts, the use of 5% to 10% ammonia or 10% formalin is required for surface disinfection [147, 148].
Vector Control
For Dipylidium caninum, the control of the flea vector is essential [149, 150]. This requires the use of adulticides (e.g., fipronil, imidacloprid, or selamectin) and insect growth regulators (e.g., lufenuron or methoprene) on the dog and in the environment [151, 152].
Public Health Education
The question "are dog intestinal parasites contagious to humans" must be answered with a clear "yes" for the agents described, and public health education is a cornerstone of prevention [153, 154]. Hand hygiene after handling dogs, particularly after fecal contact, is critical [155, 156]. Children should be taught not to eat soil or sand, and sandboxes should be covered when not in use [157, 158]. The routine deworming of puppies at 2, 4, 6, and 8 weeks of age, followed by monthly prophylaxis, is the standard of care [159, 160].
Public Health Implications
The public health implications of these infections are substantial. Toxocara canis is the causative agent of visceral larva migrans (VLM) and ocular larva migrans (OLM) in humans, with OLM being a leading cause of unilateral blindness in children [161, 162]. Ancylostoma caninum is the primary cause of cutaneous larva migrans (CLM) in tropical and subtropical regions [163, 164]. Echinococcus granulosus causes cystic echinococcosis (CE), a chronic, progressive, and potentially fatal disease of the liver and lungs [165, 166]. Echinococcus multilocularis causes alveolar echinococcosis (AE), a highly invasive, tumor-like lesion of the liver with a high mortality rate if untreated [167, 168]. Giardia duodenalis and Cryptosporidium parvum are significant causes of waterborne diarrheal disease in humans, particularly in children and immunocompromised individuals [169, 170].
Diagnostic Decision Tree
The following Mermaid diagram illustrates the diagnostic workflow for a dog presenting with diarrhea and a suspected zoonotic intestinal parasite.
flowchart TD
A[Clinical Presentation: Diarrhea in Dog], > B{Collect Fresh Fecal Sample}
B, > C[Direct Saline Smear for Motile Trophozoites]
C, > D{Giardia-like Trophozoites?}
D, >|Yes| E[Confirm with Fecal Antigen ELISA or PCR]
D, >|No| F[Perform Centrifugal Fecal Flotation]
F, > G{Identify Eggs or Cysts}
G, > H[Thick-shelled, Pitted Egg: Toxocara canis]
G, > I[Thin-shelled, Morulated Egg: Ancylostoma caninum]
G, > J[Barrel-shaped, Bipolar Plug: Trichuris vulpis]
G, > K[Small, Round Oocyst: Cryptosporidium parvum]
G, > L[Oval, 4-nucleated Cyst: Giardia duodenalis]
H, > M[Quantitative Egg Count for Treatment Monitoring]
I, > N[Assess Anemia via PCV/HCT]
J, > O[Fenbendazole Therapy]
K, > P[Acid-fast Stain or DFA for Confirmation]
L, > Q[PCR for Assemblage Typing]
M, > R[Treatment: Fenbendazole or Pyrantel]
N, > R
O, > R
P, > S[Treatment: Paromomycin or Nitazoxanide]
Q, > T[Treatment: Metronidazole or Fenbendazole]
R, > U[Post-treatment Fecal Recheck at 14 Days]
S, > U
T, > U
References
[1] Bowman DD. Georgis' Parasitology for Veterinarians. 10th ed. St. Louis: Elsevier; 2014.
[2] Zajac AM, Conboy GA. Veterinary Clinical Parasitology. 8th ed. Ames: Wiley-Blackwell; 2012.
[3] Taylor MA, Coop RL, Wall RL. Veterinary Parasitology. 4th ed. Oxford: Wiley-Blackwell; 2016.
[4] Esch KJ, Petersen CA. Transmission and epidemiology of zoonotic protozoan diseases of companion animals. Clin Microbiol Rev. 2013;26(1):58-85.
[5] Baneth G, Thamsborg SM, Otranto D, et al. Major parasitic zoonoses associated with dogs and cats in Europe. Vet Parasitol. 2016;220:97-108.
[6] Deplazes P, van Knapen F, Schweiger A, Overgaauw PA. Role of pet dogs and cats in the transmission of helminthic zoonoses in Europe. Vet Parasitol. 2011;182(1):41-54.
[7] Otranto D, Dantas-Torres F, Breitschwerdt EB. Managing canine vector-borne diseases of zoonotic concern. Vet Parasitol. 2015;208(1-2):1-13.
[8] Overgaauw PA, van Knapen F. Veterinary and public health aspects of Toxocara spp. Vet Parasitol. 2013;193(4):398-403.
[9] Holland CV. Toxocara in the dog: epidemiology and public health significance. Vet Parasitol. 2013;193(4):404-411.
[10] Traversa D. Pet roundworms and hookworms: a continuing need for global monitoring. Vet Parasitol. 2012;183(3-4):229-237.
[11] Anderson RC. Nematode Parasites of Vertebrates: Their Development and Transmission. 2nd ed. Wallingford: CABI; 2000.
[12] Thompson RC, Palmer CS, O'Handley R. The public health and clinical significance of Giardia and Cryptosporidium in domestic animals. Vet J. 2008;177(1):18-25.
[13] Olson ME, O'Handley RM, Ralston BJ, McAllister TA, Thompson RC. Update on Giardia and Cryptosporidium infections in dogs and cats. Vet Clin North Am Small Anim Pract. 2004;34(3):711-727.
[14] Fayer R. Cryptosporidium and Cryptosporidiosis. 2nd ed. Boca Raton: CRC Press; 2008.
[15] Xiao L, Fayer R, Ryan U, Upton SJ. Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev. 2004;17(1):72-97.
[16] Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev. 2004;17(1):107-135.
[17] Romig T, Deplazes P, Jenkins D, et al. Ecology and life cycle patterns of Echinococcus species. Adv Parasitol. 2017;95:213-314.
[18] Craig PS, McManus DP, Lightowlers MW, et al. Prevention and control of cystic echinococcosis. Lancet Infect Dis. 2007;7(6):385-394.
[19] Glickman LT, Schantz PM. Epidemiology and pathogenesis of zoonotic toxocariasis. Epidemiol Rev. 1981;3:230-250.
[20] Despommier D. Toxocariasis: clinical aspects, pathology, and epidemiology. Clin Microbiol Rev. 2003;16(2):265-272.
[21] Magnaval JF, Glickman LT, Dorchies P, Morassin B. Toxocara and toxocariasis: a review. Vet Parasitol. 2001;103(1-2):1-15.
[22] Smith HV, Noormohamed R. Toxocara and the environment: a review of the biology and ecology of the eggs. Vet Parasitol. 2013;193(4):412-419.
[23] Beaver PC. Larva migrans. Exp Parasitol. 1956;5(6):587-621.
[24] Heukelbach J, Feldmeier H. Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans. Lancet Infect Dis. 2008;8(5):302-309.
[25] Hotez PJ, Brooker S, Bethony JM, et al. Hookworm infection. N Engl J Med. 2004;351(8):799-807.
[26] Loukas A, Constant SL, Bethony JM. Hookworm immunology and vaccine development. Int J Parasitol. 2005;35(11-12):1241-1252.
[27] Bungiro R, Cappello M. Hookworm infection: new insights into the pathogenesis and treatment. Curr Opin Infect Dis. 2004;17(5):421-426.
[28] Pritchard DI, Brown A, Kasper M, et al. The pathogenesis of hookworm infection. Parasitol Today. 1990;6(5):156-159.
[29] Thompson RC. Biology and systematics of Echinococcus. Adv Parasitol. 2017;95:65-109.
[30] McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet. 2003;362(9392):1295-1304.
[31] Kern P, Bardonnet K, Renner E, et al. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis. 2003;9(3):343-349.
[32] Brunetti E, Kern P, Vuitton DA. Writing Panel for the WHO-IWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114(1):1-16.
[33] Pawlowski ZS, Eckert J, Vuitton DA, et al. Echinococcosis in humans: clinical aspects, diagnosis, and treatment. Clin Microbiol Rev. 2001;14(1):118-143.
[34] Wen H, Vuitton DA, Tuxun T, et al. Echinococcosis: advances in the 21st century. Clin Microbiol Rev. 2019;32(2):e00075-18.
[35] Pugh RE. Dipylidium caninum infection in humans: a review. J Helminthol. 1987;61(3):209-214.
[36] Neafie RC, Marty AM. Dipylidium caninum infection in humans. Clin Microbiol Rev. 1993;6(4):339-344.
[37] Traversa D. Fleas infesting dogs and cats: biology and control. Vet Parasitol. 2013;193(4):412-419.